Literature DB >> 28209367

Helicobacter pylori: The Past, Present, and Future in Management.

Amrit K Kamboj1, Thomas G Cotter1, Amy S Oxentenko2.   

Abstract

Helicobacter pylori is a common bacterial pathogen responsible for substantial gastrointestinal morbidity worldwide. Helicobacter pylori infection can be clinically challenging, given the numerous diagnostic and therapeutic options available. In this article, we provide a systematic review of H pylori epidemiology and pathogenesis. In addition, we provide a simplified approach to the diagnosis and treatment of H pylori infection, suitable for application in the primary care setting. On completion of this article, one should be able to (1) state the indications for H pylori testing; (2) identify noninvasive and invasive tests to diagnose H pylori infection; and (3) describe the advantages and disadvantages of various treatment regimens.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28209367     DOI: 10.1016/j.mayocp.2016.11.017

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  15 in total

Review 1.  Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer.

Authors:  Changchang Chen; Linjie Chen; Lijun Lin; Dazhi Jin; Yaoqiang Du; Jianxin Lyu
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-26       Impact factor: 4.813

2.  Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.

Authors:  Jia Di; Jun Zhang; Lei Cao; Ting-Ting Huang; Jun-Xia Zhang; Yan-Ni Mi; Xue Xiao; Ping-Ping Yan; Man-Li Wu; Tong Yao; Dong-Zheng Liu; Jing Liu; Yong-Xiao Cao
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

3.  Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.

Authors:  Evrim Kahramanoğlu Aksoy; Ferdane Pirinçci Sapmaz; Zeynep Göktaş; Metin Uzman; Yaşar Nazlıgül
Journal:  Med Princ Pract       Date:  2017-11-03       Impact factor: 1.927

Review 4.  Role of Selenoproteins in Bacterial Pathogenesis.

Authors:  Sarah E Sumner; Rachel L Markley; Girish S Kirimanjeswara
Journal:  Biol Trace Elem Res       Date:  2019-09-05       Impact factor: 3.738

Review 5.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

Review 6.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

7.  Sex-Specific Risk Factors Associated with Helicobacter pylori Infection Among Individuals Undergoing Health Examinations in China.

Authors:  Yumei Wu; Hui Zeng; Meiping Zhang; Chunyan Li; Yuanlin Tang; Xiufen Li; Shanyou Yuan; Qifeng Wei; Jinghua Wang; Xianjia Ning; Xiaoyin Zhang
Journal:  Int J Gen Med       Date:  2022-06-29

8.  Helicobacter pylori eradication in renal transplant candidates.

Authors:  Mariana E Maioli; Raquel F N Frange; Cintia M C Grion; Vinicius D A Delfino
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

Review 9.  Gastric cancer: genome damaged by bugs.

Authors:  Yanan Zhao; Jinglin Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To; Wei Kang
Journal:  Oncogene       Date:  2020-03-02       Impact factor: 9.867

10.  Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori.

Authors:  Hassan Tariq; Harish Patel; Muhammad Umar Kamal; Naeem Abbas; Muhammad Ameen; Sara Azam; Kishore Kumar; Madhavi Ravi; Vamshidhar Vootla; Danial Shaikh; Vamsi Amanchi; Ali N Hussain; Jasbir Makker
Journal:  Clin Exp Gastroenterol       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.